SLU7 as a new cancer target

Collaborative work demonstrating SLU7, a splicing regulator, as a new target in cancer.

Rojo C, Otero A, Elizalde M, et al. Demonstration of SLU7 as a new cancer target. Biomedicine & Pharmacotherapy. 2025 Dec;193:118854.